The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
111-124
Author(s):
Patrick Onyango
Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
125-146
Author(s):
Johann Hofmann
Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
147-163
Author(s):
Albert F. Kabore, James B. Johnston and Spencer B. Gibson
Transforming Growth Factor-β Superfamily: Evaluation as Breast Cancer Biomarkers and Preventive Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
165-182
Author(s):
V. Gupta, D. P. Harkin, H. Kawakubo and S. Maheswaran
A Rationale for Inhibiting Progesterone-Related Pathways to Combat Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
183-189
Author(s):
Michael R. Moore
Novel Fluoropyrimidines: Improving the Efficacy and Tolerability of Cytotoxic Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
191-204
Author(s):
Russell D. Petty and J. Cassidy
Targeted Histone Deacetylase Inhibition for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
205-218
Author(s):
D. M. Vigushin and R. C. Coombes
AT Islands - Their Nature and Potential for Anticancer Strategies
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
219-234
Author(s):
Jan M. Woynarowski
Machine Learning Based Pattern Recognition Applied to Microarray Data
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
7
Page:
115-131
Author(s):
Barry K. Lavine, Charles E. Davidson and William S. Rayens
Targeting FLT3 Kinase in Acute Myelogenous Leukemia: Progress, Perils, and Prospects
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
255-271
Author(s):
Michael C. Heinrich